5/18
Health Sciences
New research eyes closer integration of doulas and hospital maternity care
Projects from Penn’s new Research Center for Advancing Maternal Health Equity help determine how non-medical birth support workers can be more a part of maternal care teams.
Antibody treatment prevents graft versus host disease in advanced preclinical tests
Penn Medicine, Dana-Farber Cancer Institute, and Boston Children’s Hospital research finds single antibody treatment blocked donor T-cell attack and increased survival rates in preclinical models.
Using video to unpack bias in nurse-maternity patient communications
A Moore Fellowship funds a three-year research project for Rebecca Clark.
Challenges and advances in brain-computer interfaces
Following FDA approval for tech startups to begin human clinical trials for brain-computer interfacing technologies, Penn Today met with Anna Wexler of the Perelman School of Medicine to discuss the promising possibilities and potential pitfalls of neurotechnology.
Breaking down barriers to blood donation for LGBTQ+ people
New blood donation rules empower more LGBTQ+ people to give and expand the blood supply.
Auto-nudges increase emergency department treatment of opioid use disorder
A Penn Medicine study finds assessment for opioid withdrawal doubles when a triage screening question is paired with electronic health record automated prompts.
A better understanding into how genes make us prone to allergies
Slight alterations in the ETS1 protein level can lead to allergic inflammation.
The problem of race-specific tests in lung care
Using different baseline lung function for Black and white patients leads to lower rates of diagnosis in Black patients, say Penn LDI fellows.
New, precise, and efficient DNA sequencing method may lead to easier testing and earlier cancer detection
The technique, created by Penn Medicine researchers, requires smaller DNA samples for testing and opens up potential new opportunities for next-generation diagnostics.
RNA nanoparticle therapy stops the spread of incurable bone marrow cancer
By creating a roadblock in cancer’s commute through the body, researchers removed a longstanding barrier in the treatment of multiple myeloma.
In the News
What’s going on with tranq?
Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.
FULL STORY →
It’s time to end the Medicare-Medicaid merry-go-round
In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.
FULL STORY →
The quest for treatments to keep weight off after Ozempic
Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.
FULL STORY →
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →